Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

The Independent Effects of Frailty and Comorbidity On the Quality of Life in MDS Patients

Rena Buckstein, MD, Shabbir M.H. Alibhai, MD, Dina Khalaf, MD, Adam Lam, Alex Mamedov, Lisa Chodirker, MD, Liying Zhang, PhD, Martha Lenis, Matthew Cheung, MD, Jeannie Callum, MD, Janey Hsiao, MD, Yulia Lin, MD, Kenneth Rockwood, MD, Richard A. Wells, MD, DPhil

Blood (2012) 120 (21): 699.

https://doi.org/10.1182/blood.V120.21.699.699

Published: 2012

Journal Articles

The Effects of Azacitidine On Quality of Life: A Prospective Longitudinal Assessment

Eric Tseng, MD, FRCPC, Richard A. Wells, MD, DPhil, Shabbir MH Alibhai, MD, MSc, FRCP(C), Adam Lam, Alex Mamedov, Lisa Chodirker, MD, Liying Zhang, PhD, Dina Khalaf, MD, Anca Prica, MD, Martha Lenis, Rena Buckstein, MD

Blood (2012) 120 (21): 4938.

https://doi.org/10.1182/blood.V120.21.4938.4938

Published: 2012

Journal Articles

Validation of the Nordic Scoring System for Erythropoietic Stimulating Agents in MDS Using IWG 2006 Erythroid Response Criteria

Jennifer Jayakar, Richard A. Wells, MD, DPhil, Dina Khalaf, MD, Alex Mamedov, Adam Lam, Martha Lenis, Rena Buckstein, MD

Blood (2012) 120 (21): 1721.

https://doi.org/10.1182/blood.V120.21.1721.1721

Published: 2012

Journal Articles

Initial Transfusion Rate Predicts Survival in MDS

Lap Shu Alan Chan, MSc, Roman Shapiro, BSc, Rena Buckstein, MD, FRCPC, Yulia Lin, MD, Jeannie Callum, MD, Lisa Chodirker, MD, FRCPC, Christina D. Lee, MD, Adam Lam, Alexandre Mamedov, Richard A. Wells, MD, DPhil

Blood (2011) 118 (21): 2791.

https://doi.org/10.1182/blood.V118.21.2791.2791

Published: 2011

Journal Articles

The Effects of Azacitidine on Quality of Life Measured Longitudinally In MDS Patients Treated at a Tertiary Care Center

Sarah A. Ingber, MD, Kim Thompson, Adam Lam, Alex Mamedov, Liying Zhang, PhD, Alibhai Shabbir, MD, David Good, MD, Alden Chesney, MD, Marciano D. Reis, MD, Matthew Cheung, MD, Vicky Harris, RN, Richard A. Wells, MD, DPhil, Rena Buckstein, MD

Blood (2010) 116 (21): 2571.

https://doi.org/10.1182/blood.V116.21.2571.2571

Published: 2010

Journal Articles

Arginase and YKL-40, Effectors of Immunosuppressive Myeloid Cells, Are Over-Expressed In the Bone Marrow of Most Chronic Myelomonocytic Leukemia Patients, and Are Potential Prognostic Biomarkers In Myelodysplastic Syndrome

Michael J. Rauh, MD, PhD, Deeksha Mahendru, BSc, Roman Shapiro, BSc, Alden Chesney, MD, David Good, MD, Marciano D. Reis, MD, Adam Lam, Gerald Krystal, PhD, Rena Buckstein, MD, FRCPC, Richard A. Wells, MD, DPhil

Blood (2010) 116 (21): 1855.

https://doi.org/10.1182/blood.V116.21.1855.1855

Published: 2010

Journal Articles

Transfusion Dependence and Low Hemoglobin Have the Greatest Impact On Quality of Life (QOL) in MDS Patients - a Tertiary Care Cross Sectional and Longitudinal Study.

Rena Buckstein, MD, Shabbir Alibhai, MD, Adam Lam, Liying Zhang, Alex Mamedov, Matthew C Cheung, MD, Jeannie Callum, MD, Eugenia Piliotis, MD, Janey Tsiao, MD, Yulia Lin, MD, Richard A. Wells, MD, DPhil

Blood (2009) 114 (22): 2500.

https://doi.org/10.1182/blood.V114.22.2500.2500

Published: 2009

Journal Articles

Iron Overload and Haematopoiesis in MDS: Does Blood Transfusion Promote Progression to AML?

Lap Shu Alan Chan, Rena Buckstein, MD, Marciano D. Reis, MD, Alden Chesney, II, MD, Adam Lam, Matthew C Cheung, MD, Eugenia Piliotis, MD, Lilly Chunhong Gu, MD, PhD, Richard A. Wells, MD, DPhil

Blood (2008) 112 (11): 2685.

https://doi.org/10.1182/blood.V112.11.2685.2685

Published: 2008

NARROW

The Independent Effects of Frailty and Comorbidity On the Quality of Life in MDS Patients

The Effects of Azacitidine On Quality of Life: A Prospective Longitudinal Assessment

Validation of the Nordic Scoring System for Erythropoietic Stimulating Agents in MDS Using IWG 2006 Erythroid Response Criteria

Initial Transfusion Rate Predicts Survival in MDS

The Effects of Azacitidine on Quality of Life Measured Longitudinally In MDS Patients Treated at a Tertiary Care Center

Arginase and YKL-40, Effectors of Immunosuppressive Myeloid Cells, Are Over-Expressed In the Bone Marrow of Most Chronic Myelomonocytic Leukemia Patients, and Are Potential Prognostic Biomarkers In Myelodysplastic Syndrome

Transfusion Dependence and Low Hemoglobin Have the Greatest Impact On Quality of Life (QOL) in MDS Patients - a Tertiary Care Cross Sectional and Longitudinal Study.

Iron Overload and Haematopoiesis in MDS: Does Blood Transfusion Promote Progression to AML?

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only